WB
CRL icon

WesBanco Bank’s Charles River Laboratories CRL Stock Holding History

WesBanco Bank’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,489
Closed -$423K – 553
2022
Q1 		$423K Sell
1,489
-111
-7% -$34.2K 0.02% 439
2021
Q4 		$603K Sell
1,600
-4,401
-73% -$1.71M 0.02% 394
2021
Q3 		$2.48M Buy
6,001
+45
+0.8% +$18.7K 0.1% 180
2021
Q2 		$2.2M Sell
5,956
-5,382
-47% -$1.8M 0.08% 198
2021
Q1 		$3.29M Buy
+11,338
New +$3.15M 0.13% 152
2020
Q3 		$3.26M Hold
14,377
– – 0.15% 133
2020
Q2 		$2.51M Hold
14,377
– – 0.12% 148
2020
Q1 		$1.81M Buy
14,377
+46
+0.3% +$6.9K 0.11% 164
2019
Q4 		$2.19M Buy
14,331
+47
+0.3% +$6.51K 0.1% 176
2019
Q3 		$1.89M Hold
14,284
– – 0.09% 190
2019
Q2 		$2.03M Hold
14,284
– – 0.1% 185
2019
Q1 		$2.08M Hold
14,284
– – 0.1% 171
2018
Q4 		$1.62M Hold
14,284
– – 0.1% 172
2018
Q3 		$1.92M Hold
14,284
– – 0.09% 187
2018
Q2 		$1.6M Buy
14,284
+1,855
+15% +$201K 0.08% 206
2018
Q1 		$1.33M Buy
+12,429
New +$1.34M 0.07% 222
2017
Q4 		– Sell
-8,344
Closed -$901K – 441
2017
Q3 		$901K Sell
8,344
-139
-2% -$14.3K 0.05% 261
2017
Q2 		$858K Buy
8,483
+2,634
+45% +$242K 0.05% 262
2017
Q1 		$526K Buy
5,849
+2,632
+82% +$224K 0.03% 319
2016
Q4 		$245K Sell
3,217
-2,885
-47% -$219K 0.01% 433
2016
Q3 		$509K Hold
6,102
– – 0.03% 323
2016
Q2 		$503K Buy
6,102
+2,315
+61% +$191K 0.03% 321
2016
Q1 		$288K Buy
+3,787
New +$280K 0.02% 388

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WesBanco Bank's CRL Position: Q2 2022 in Review

WesBanco Bank sold out of Charles River Laboratories (CRL) in Q2 2022, closing a stake of 1,489 shares — an estimated $423K sold.

WesBanco Bank first reported a position in CRL in Q1 2016 and held it in 23 quarters. The position peaked at $3.29M in Q1 2021. 627 funds tracked by Wall St. Rank hold CRL as of Q2 2022.

  • WesBanco Bank reported no remaining Charles River Laboratories position as of Q2 2022 after selling out during the quarter.
  • WesBanco Bank sold 1,489 Charles River Laboratories shares in Q2 2022, an estimated $423K.
  • WesBanco Bank first reported a position in Charles River Laboratories in Q1 2016 and held it in 23 quarters.
  • WesBanco Bank's Charles River Laboratories position peaked at $3.29M in Q1 2021.
  • 627 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2022.

Based on WesBanco Bank's 13F filing for Q2 2022, filed 18 Jul 2022.